Chronic amitriptyline treatment induces hippocampal NGFI-A, glucocorticoid receptor and mineralocorticoid receptor mRNA expression in rats

Molecular Brain Research

Volumn 62, Issue 1, 1998, Pages 92-95

  Johansson, Inga Maj ^a   Bjartmar, Lisa ^b   Marcusson, Jan ^b   Ross, Svante B ^c   Seckl, Jonathan R ^d   Olsson, Tommy ^a  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^b LINKÖPING UNIVERSITY   (Sweden)

^c Astra Arcus AB   (Sweden)

^d WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

Antidepressant; Glucocorticoid receptor; Hippocampus; NGFI A; Transcription factor

Indexed keywords

AMITRIPTYLINE; GLUCOCORTICOID RECEPTOR; MINERALOCORTICOID RECEPTOR; NERVE GROWTH FACTOR;

ANIMAL EXPERIMENT; ARTICLE; DRUG EFFECT; HIPPOCAMPUS; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; RECEPTOR DENSITY; TISSUE DISTRIBUTION;

AMITRIPTYLINE; ANIMALS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; DNA-BINDING PROTEINS; EARLY GROWTH RESPONSE PROTEIN 1; GENE EXPRESSION REGULATION; HIPPOCAMPUS; IMMEDIATE-EARLY PROTEINS; INJECTIONS, SUBCUTANEOUS; MALE; NEURONAL PLASTICITY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GLUCOCORTICOID; RECEPTORS, MINERALOCORTICOID; RNA, MESSENGER; TRANSCRIPTION FACTORS;

ANIMALIA; EUKARYOTA; HIPPOCAMPUS HIPPOCAMPUS;

EID: 0032512122     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(98)00243-5     Document Type: Article

References (17)

1. Brady L.S., Whitfield H.J., Fox R.J., Gold P.W., Herkenham M. Long-term antidepressant administration alters corticotropin-releasing hormone, tyrosine hydroxylase, and mineralocorticoid receptor gene expression in rat brain. Therapeutic implications. J. Clin. Invest. 87:1991;831-837.
2. Carroll B.J., Curtis G.C., Mendels J. Cerebrospinal fluid and plasma free cortisol concentrations in depression. Psychol. Med. 6:1976;235-244.
3. Diorio J., Donaldson L., Yau J., Sharma S., Seckl J.R., Meaney M.J. Postnatal handling alters AP-2, NGFI-A, NGFI-B mRNA expression in rat hippocampus. Soc. Neurosci. Abstr. 20:1994;1317.
4. Encio I.J., Detera Wadleigh S.D. The genomic structure of the human glucocorticoid receptor. J. Biol. Chem. 266:1991;7182-7188.
5. Holsboer F., Barden N. Antidepressants and hypothalamic-pituitary-adrenocortical regulation. Endocr. Rev. 17:1996;187-205.
6. Linkowski P., Mendlewicz J., Kerkhofs M., Leclercq R., Golstein J., Brasseur M., Copinschi G., Van Cauter E. 24-h profiles of adrenocorticotropin, cortisol, and growth hormone in major depressive illness: effect of antidepressant treatment. J. Clin. Endocrinol. Metab. 65:1987;141-152.
7. Morinobu S., Strausbaugh H., Terwilliger R., Duman R.S. Regulation of c-Fos and NGF1-A by antidepressant treatments. Synapse. 25:1997;313-320.
8. E.J. Nestler, R.S. Duman, Intracellular messenger pathways as mediators of neural plasticity, in: F.E. Bloom, D.J. Kupfer (Ed.), Psychopharmacology: The Fourth Generation of Progress, Raven Press, New York, 1995, pp. 695-704.
9. Olsson T., Mohammed A.H., Donaldson L.F., Henriksson B.G., Seckl J.R. Glucocorticoid receptor and NGFI-A gene expression are induced in the hippocampus after environmental enrichment in adult rats. Molecular Brain Research. 23:1994;349-353.
10. Reul J.M., Labeur M.S., Grigoriadis D.E., De S.E., Holsboer F. Hypothalamic-pituitary-adrenocortical axis changes in the rat after long-term treatment with the reversible monoamine oxidase-A inhibitor moclobemide. Neuroendocrinology. 60:1994;509-519.
11. Reul J.M., Stec I., Soder M., Holsboer F. Chronic treatment of rats with the antidepressant amitriptyline attenuates the activity of the hypothalamic-pituitary-adrenocortical system. Endocrinology. 133:1993;312-320.
12. Richardson C.L., Tate W.P., Mason S.E., Lawlor P.A., Dragunow M., Abraham W.C. Correlation between the induction of an immediate early gene, zif/268, and long-term potentiation in the dentate gyrus. Brain Res. 580:1992;147-154.
13. Seckl J.R., Dickson K.L., Fink G. Central 5,7-dihydroxytryptamine lesions decrease hippocampal glucocorticoid and mineralocorticoid receptor messenger ribonucleic acid expression. J. Neuroendocrinol. 2:1990;911-916.
14. Seckl J.R., Fink G. Antidepressants increase glucocorticoid and mineralocorticoid receptor mRNA expression in rat hippocampus in vivo. Neuroendocrinology. 55:1992;621-626.
15. Seckl J.R., Olsson T. Glucocorticoid hypersecretion and the age-impaired hippocampus: cause or effect? J. Endocrinol. 145:1995;201-211.
16. Yau J.L., Dow R.C., Fink G., Seckl J.R. Medial septal cholinergic lesions increase hippocampal mineralocorticoid and glucocorticoid receptor messenger RNA expression. Brain Res. 577:1992;155-160.
17. Yau J.L., Olsson T., Morris R.G., Noble J., Seckl J.R. Decreased NGFI-A gene expression in the hippocampus of cognitively impaired aged rats. Molecular Brain Research. 42:1996;354-357.